How the Immune System Fights Infections: Innate and Adaptive Responses
The immune system uses two coordinated defense systems to fight infections. Learn how innate and adaptive immunity work, from pattern recognition to antibody production.
A Two-Tier Defense System Built Over Evolution
The human immune system did not emerge fully formed. Over hundreds of millions of years of evolution, two distinct but deeply interconnected defense systems developed. The first — innate immunity — responds rapidly but broadly, using pre-programmed recognition patterns to detect invaders within hours. The second — adaptive immunity — takes days to mobilize but generates exquisitely specific responses and remembers the pathogens it has defeated.
Every successful immune response against infection involves both systems. Innate immunity contains the initial threat and alerts the adaptive system. Adaptive immunity eliminates the pathogen specifically and creates immunological memory that speeds future responses. A failure in either layer — whether from immunodeficiency or pathogen evasion — allows infections to overwhelm the host.
Physical and Chemical Barriers: The First Line
Before either immune system engages, physical and chemical barriers prevent most pathogens from entering the body:
- Skin: Intact skin is an impenetrable barrier to most microorganisms; its low pH and antimicrobial peptides (defensins) inhibit bacterial growth
- Mucous membranes: Line the respiratory tract, gastrointestinal tract, and urogenital tract; trap pathogens in mucus, which is cleared by cilia (mucociliary escalator in airways)
- Stomach acid: pH 1.5–3.5 kills most ingested bacteria
- Normal microbiome: Commensal bacteria compete with pathogens for nutrients and receptor sites; dysbiosis increases susceptibility to infections like Clostridioides difficile
- Lysozyme and lactoferrin: Antimicrobial proteins in saliva, tears, and breast milk that damage bacterial cell walls
The Innate Immune System
When a pathogen breaches physical barriers, innate immune cells detect it within minutes. These cells recognize conserved molecular patterns shared by broad classes of pathogens — patterns that human cells do not possess. This recognition occurs through pattern recognition receptors (PRRs), including:
- Toll-like receptors (TLRs): Detect pathogen-associated molecular patterns (PAMPs) such as lipopolysaccharide (LPS) from Gram-negative bacteria, flagellin, viral RNA, and fungal components; 10 TLRs are expressed in humans
- NOD-like receptors (NLRs): Intracellular sensors detecting bacterial peptidoglycans and danger signals from damaged host cells; some form inflammasomes that activate IL-1β
- RIG-I-like receptors: Cytoplasmic sensors detecting viral RNA in infected cells
Key Innate Immune Cells
| Cell Type | Location | Primary Functions |
|---|---|---|
| Neutrophils | Blood; recruited to tissues | First responders; phagocytose and kill bacteria via oxidative burst; release neutrophil extracellular traps (NETs) |
| Macrophages | Resident in all tissues | Phagocytosis; cytokine production; antigen presentation to T cells; long-lived inflammatory orchestrators |
| Dendritic cells | Skin, mucosa, lymph nodes | Professional antigen-presenting cells; bridge innate and adaptive immunity; activate naive T cells |
| Natural killer (NK) cells | Blood, lymphoid tissues | Kill virus-infected and tumor cells that have downregulated MHC I; release perforin and granzymes |
| Mast cells | Skin, gut, lung mucosa | Release histamine and cytokines upon pathogen detection; important in parasite defense and allergy |
Inflammation: The Innate Response in Action
Within minutes to hours of infection, activated macrophages and mast cells release cytokines — signaling proteins that coordinate the immune response. The cardinal cytokines of acute inflammation include TNF-alpha, IL-1, and IL-6. Their effects are systemic:
- Fever (induced by prostaglandin E2 acting on the hypothalamus) — raises body temperature to inhibit pathogen replication
- Neutrophil recruitment — cytokines cause blood vessel endothelial cells to express adhesion molecules that capture circulating neutrophils, directing them to the infection site
- Acute phase response — IL-6 stimulates the liver to produce C-reactive protein (CRP), complement proteins, and fibrinogen
- Vasodilation and increased vascular permeability — causing the redness and swelling of inflammation
The complement system — a cascade of over 30 proteins — is activated by pathogen surfaces (alternative pathway), antibody-antigen complexes (classical pathway), or carbohydrate patterns (lectin pathway). The cascade produces opsonins (C3b) that coat pathogens for phagocytosis, recruits inflammatory cells (C5a), and forms the membrane attack complex (MAC) that directly lyses bacterial membranes.
The Adaptive Immune System
If innate immunity cannot contain an infection within the first few days, the adaptive immune response becomes critical. Adaptive immunity is characterized by specificity, diversity, and memory.
Antigen Presentation and T Cell Activation
Dendritic cells phagocytose pathogens at infection sites, process their proteins into peptide fragments, and migrate to lymph nodes. There, they present these peptides on MHC (major histocompatibility complex) molecules to naive T cells. A naive T cell must receive three signals to activate:
- T cell receptor (TCR) recognition of its specific peptide-MHC complex
- Co-stimulatory signal (CD28 on T cell + B7 on dendritic cell)
- Cytokine signals from the innate immune environment (determine T cell differentiation fate)
Activated T cells proliferate massively (clonal expansion) and differentiate into functional subsets:
- CD8+ cytotoxic T cells (CTLs): Kill virus-infected cells by injecting perforin and granzymes; essential for clearing intracellular pathogens
- CD4+ helper T cells: Provide help to B cells, enhance macrophage killing, coordinate the adaptive response; subtypes include Th1 (bacterial/intracellular), Th2 (parasites/allergy), Th17 (fungi/bacteria), and Treg (regulation)
B Cells and Antibody Production
B cells carry surface immunoglobulin receptors that directly bind antigens. With T helper cell assistance, activated B cells proliferate and differentiate into plasma cells, which secrete soluble antibodies (immunoglobulins). Antibodies fight infection by:
- Neutralization: Binding toxins or pathogen surface proteins to block their activity or entry into host cells
- Opsonization: Coating pathogens to enhance phagocytosis by macrophages and neutrophils
- Complement activation: Antibody-antigen complexes activate the classical complement pathway
- Antibody-dependent cellular cytotoxicity (ADCC): NK cells recognize antibody-coated targets and kill them
Immunological Memory
| Memory Cell Type | Location | Function During Reinfection |
|---|---|---|
| Central memory T cells (TCM) | Secondary lymphoid organs | Rapid proliferation and differentiation upon reexposure |
| Effector memory T cells (TEM) | Non-lymphoid tissues (lung, gut) | Immediate effector function at tissue sites |
| Long-lived plasma cells | Bone marrow niches | Continuous antibody secretion for years to decades |
| Memory B cells | Circulation, spleen, lymph nodes | Rapid antibody production upon reexposure; undergo additional somatic hypermutation for higher-affinity antibodies |
Immunological memory is the basis of vaccination: exposure to a killed pathogen, protein antigen, or mRNA-encoded antigen generates memory cells. Upon encounter with the real pathogen, the secondary immune response is so rapid and powerful that infection is cleared before causing significant illness.
Pathogen Evasion Strategies
Successful pathogens have evolved mechanisms to evade or subvert immune responses. HIV infects and destroys CD4+ T helper cells — the coordinators of adaptive immunity — causing progressive immune deficiency. Mycobacterium tuberculosis survives inside macrophage phagosomes by preventing their acidification. Influenza virus mutates its surface antigens (antigenic drift and shift) to avoid recognition by existing antibodies. Understanding these evasion strategies drives vaccine design and immunotherapy development.
This article is for informational purposes only. Consult a qualified healthcare professional before making any health decisions.
Related Articles
medical conditions
ADHD in Adults: Diagnosis, Treatment, and Science
Late diagnosis trends, executive function deficit models, stimulant vs. non-stimulant comparisons, neuroimaging findings, and lifestyle strategies for adult ADHD.
9 min read
medical conditions
Alzheimer's Disease: 7 Stages, Treatments, and 2023 Advances
From GDS stage 1 to late-stage dementia, learn how Alzheimer's progresses, how lecanemab slows decline by 18%, and what ARIA side effects mean for patients.
9 min read
medical conditions
Atrial Fibrillation Treatment: Rate vs. Rhythm Control and Stroke Risk
AFib affects 37 million people globally. Learn the CHA₂DS₂-VASc stroke risk score, rate vs. rhythm control debate after EAST-AFNET 4, catheter ablation success rates, and DOAC vs. warfarin comparisons.
9 min read
medical conditions
Autoimmune Diseases Explained: Causes, Types, and Treatments
Learn how autoimmune diseases develop, what causes the immune system to attack healthy tissue, the most common types, diagnostic challenges, and treatment approaches.
9 min read